• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

血清血管生成素相关生长因子 (AGF) 水平在多囊卵巢综合征中升高。

Serum levels of angiopoietin-related growth factor (AGF) are increased in polycystic ovary syndrome.

机构信息

Department of Gynecology and Obstetrics, Cumhuriyet University School of Medicine, Sivas, Turkey.

出版信息

J Investig Med. 2012 Jun;60(5):813-7. doi: 10.2310/JIM.0b013e31824e9900.

DOI:10.2310/JIM.0b013e31824e9900
PMID:22406517
Abstract

BACKGROUND

Polycystic ovary syndrome (PCOS) is a frequent reproductive and metabolic disorder associated with insulin resistance. Recently, angiopoietins were identified in the systemic circulation and have been designated angiopoietinlike proteins (ANGPTL). More recently, it is shown that angiopoietin-related growth factor (AGF, also called ANGPTL6) directly regulate lipid, glucose, and energy metabolism independent of angiogenic effects in animal studies. The aim of this study was to determine whether there is an association between AGF and PCOS.

METHODS

The study included 55 [corrected] patients with PCOS and 30 healthy control women. We analyzed serum levels of AGF and other biochemical and anthropometric markers in all the subjects.

RESULTS

This study showed that serum AGF levels were significantly higher in the subjects with PCOS (102.28 ng/mL) than those in the healthy control group (63.08 ng/mL; P < 0.001). Body mass index (24.33 vs 22.11 kg/m; P = 0.017), free testosterone (2.81 vs 2.17 pmol/L; P = 0.009), androstenedione (3.28 vs 2.92 nmol/L; P = 0.033), 17-hydroxyprogesterone (2.72 vs 2.09 ng/mL; P = 0.039), homeostasis model of assessment-insulin resistance (2.65 vs 1.9; P = 0.016), and fasting glucose (107.09 vs 96.18 mmol/L; P = 0.001) were found significantly higher in PCOS group than in control group. But there was no correlation between AGF and these parameters in PCOS group. In addition, no correlation between the AGF and other distinctive features of PCOS was found.

CONCLUSIONS

Serum AGF levels were paradoxically increased in patients with PCOS in comparison with data of animal experiments. Further studies are needed to better elucidate the physiologic significance of circulating AGF in human disease.

摘要

背景

多囊卵巢综合征(PCOS)是一种常见的生殖和代谢疾病,与胰岛素抵抗有关。最近,血管生成素在全身循环中被发现,并被指定为血管生成素样蛋白(ANGPTL)。最近,研究表明血管生成素相关生长因子(AGF,也称为 ANGPTL6)在动物研究中独立于血管生成作用直接调节脂质、葡萄糖和能量代谢。本研究旨在确定 AGF 与 PCOS 是否存在关联。

方法

本研究纳入了 55 例 PCOS 患者和 30 名健康对照女性。我们分析了所有受试者的血清 AGF 水平和其他生化及人体测量标志物。

结果

本研究显示,PCOS 患者的血清 AGF 水平(102.28ng/ml)明显高于健康对照组(63.08ng/ml;P<0.001)。体重指数(24.33 与 22.11kg/m;P=0.017)、游离睾酮(2.81 与 2.17pmol/L;P=0.009)、雄烯二酮(3.28 与 2.92nmol/L;P=0.033)、17-羟孕酮(2.72 与 2.09ng/ml;P=0.039)、稳态模型评估-胰岛素抵抗(2.65 与 1.9;P=0.016)和空腹血糖(107.09 与 96.18mmol/L;P=0.001)在 PCOS 组中明显高于对照组。但在 PCOS 组中,AGF 与这些参数之间无相关性。此外,AGF 与 PCOS 的其他特征之间也没有相关性。

结论

与动物实验数据相比,PCOS 患者的血清 AGF 水平异常升高。需要进一步研究以更好地阐明循环 AGF 在人类疾病中的生理意义。

相似文献

1
Serum levels of angiopoietin-related growth factor (AGF) are increased in polycystic ovary syndrome.血清血管生成素相关生长因子 (AGF) 水平在多囊卵巢综合征中升高。
J Investig Med. 2012 Jun;60(5):813-7. doi: 10.2310/JIM.0b013e31824e9900.
2
Serum levels of angiopoietin-related growth factor are increased in metabolic syndrome.代谢综合征患者血清血管生成素相关生长因子水平升高。
Metabolism. 2011 Apr;60(4):564-8. doi: 10.1016/j.metabol.2010.05.013. Epub 2010 Aug 2.
3
Serum angiopoietin-related growth factor (AGF) levels are elevated in gestational diabetes mellitus and associated with insulin resistance.妊娠糖尿病患者血清血管生成素相关生长因子(AGF)水平升高,且与胰岛素抵抗相关。
Ginekol Pol. 2012 Oct;83(10):749-53.
4
Elevated serum levels of free insulin-like growth factor I in polycystic ovary syndrome.多囊卵巢综合征患者血清游离胰岛素样生长因子I水平升高。
J Clin Endocrinol Metab. 1999 Sep;84(9):3030-5. doi: 10.1210/jcem.84.9.5941.
5
Serum resistin and adiponectin levels in young non-obese women with polycystic ovary syndrome.年轻非肥胖多囊卵巢综合征女性血清抵抗素和脂联素水平。
Gynecol Endocrinol. 2010 Mar;26(3):161-6. doi: 10.3109/09513590903247816.
6
Serum levels of angiopoietin-related growth factor in diabetes mellitus and chronic hemodialysis.糖尿病和慢性血液透析患者血清血管生成素相关生长因子水平
Metabolism. 2009 Apr;58(4):547-51. doi: 10.1016/j.metabol.2008.11.016.
7
Serum levels of angiopoietin-related growth factor are increased in preeclampsia.
Am J Hypertens. 2009 Mar;22(3):314-8. doi: 10.1038/ajh.2008.340. Epub 2008 Dec 4.
8
High-sensitivity C-reactive protein (hs-CRP) levels and its relationship with components of polycystic ovary syndrome in Indian adolescent women with polycystic ovary syndrome (PCOS).印度患有多囊卵巢综合征(PCOS)的青春期女性的高敏C反应蛋白(hs-CRP)水平及其与多囊卵巢综合征各组分的关系。
Gynecol Endocrinol. 2014 Nov;30(11):781-4. doi: 10.3109/09513590.2014.924099. Epub 2014 Aug 19.
9
Testosterone to dihydrotestosterone ratio as a new biomarker for an adverse metabolic phenotype in the polycystic ovary syndrome.睾酮与双氢睾酮比值作为多囊卵巢综合征不良代谢表型的新型生物标志物。
J Clin Endocrinol Metab. 2015 Feb;100(2):653-60. doi: 10.1210/jc.2014-2523. Epub 2014 Nov 11.
10
Alterations of angiopoietin-related growth factor (Angptl6) during pregnancy and in pre-eclampsia.孕期及子痫前期血管生成素相关生长因子(Angptl6)的变化
J Obstet Gynaecol Res. 2013 Jun;39(6):1137-41. doi: 10.1111/jog.12039. Epub 2013 May 30.

引用本文的文献

1
Serum Levels of Angiopoietin-Like Protein 6 (ANGPTL6) in Iranian Women with Polycystic Ovary Syndrome.伊朗多囊卵巢综合征女性血清血管生成素样蛋白6(ANGPTL6)水平
J Reprod Infertil. 2025 Jan-Mar;26(1):50-57. doi: 10.18502/jri.v26i1.18781.
2
Multidimensional Biomarker Analysis Including Mitochondrial Stress Indicators for Nonalcoholic Fatty Liver Disease.多维度生物标志物分析,包括非酒精性脂肪性肝病的线粒体应激指标。
Gut Liver. 2022 Mar 15;16(2):171-189. doi: 10.5009/gnl210106.
3
Increased Serum Angiopoietin-Like 6 Ahead of Metabolic Syndrome in a Prospective Cohort Study.
前瞻性队列研究中代谢综合征发生前血清血管生成素样蛋白 6 的增加。
Diabetes Metab J. 2019 Aug;43(4):521-529. doi: 10.4093/dmj.2018.0080. Epub 2019 Mar 29.